Xilio Therapeutics
Stock Forecast, Prediction & Price Target

Xilio Therapeutics Financial Estimates

Xilio Therapeutics Revenue Estimates

Xilio Therapeutics EBITDA Estimates

Xilio Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $18.75M
Low: $18.75M
High: $18.75M
avg. 0%
Avg: $3.12M
Low: $3.12M
High: $3.12M
avg. -83.33%
Avg: $500K
Low: $500K
High: $500K
avg. -84%
Avg: $47.05M
Low: $47.05M
High: $47.05M
avg. 9310%
Net Income
 
% change YoY
$-74.30M
 
N/A
$-87.29M
 
-17.48%
$-76.40M
 
12.47%
Avg: $-70.31M
Low: $-54.99M
High: $274.96K
avg. 7.97%
Avg: $-121.11M
Low: $-54.99M
High: $-13.19M
avg. -72.24%
Avg: $-11.54M
Low: $-11.54M
High: $-11.54M
avg. 90.46%
Avg: $-9.62M
Low: $-9.62M
High: $-9.62M
avg. 16.66%
EBITDA
 
% change YoY
$-75.04M
 
N/A
$-89.14M
 
-18.79%
$-73.80M
 
17.21%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$2.72
 
N/A
-$3.19
 
-17.27%
-$2.78
 
12.85%
Avg: -$1.2
Low: -$2
High: $0.01
avg. 56.95%
Avg: -$1.49
Low: -$2
High: -$0.48
avg. -24.23%
Avg: -$0.42
Low: -$0.42
High: -$0.42
avg. 71.74%
Avg: -$0.35
Low: -$0.35
High: -$0.35
avg. 16.66%
Operating Expenses
 
% change YoY
$75.04M
 
N/A
$89.14M
 
18.79%
$79.13M
 
-11.23%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Xilio Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 10.71% in 2025-2028.

We have gathered data from 2 analysts. Their low estimate is -54.99M, average is -70.31M and high is 274.96K.

What is Xilio Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 2285.66% in 2025-2028.

We have gathered data from 2 analysts. Their low revenue estimate is $18.75M, average is $18.75M and high is $18.75M.

What is Xilio Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 30.28% in 2025-2028.

We have gathered data from 2 analysts. Their low earnings per share estimate is -$2, average is -$1.2 and high is $0.01.